1. Home
  2. UNCY vs MDIA Comparison

UNCY vs MDIA Comparison

Compare UNCY & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • MDIA
  • Stock Information
  • Founded
  • UNCY 2016
  • MDIA 2019
  • Country
  • UNCY United States
  • MDIA United States
  • Employees
  • UNCY N/A
  • MDIA N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • MDIA Broadcasting
  • Sector
  • UNCY Health Care
  • MDIA Consumer Discretionary
  • Exchange
  • UNCY Nasdaq
  • MDIA Nasdaq
  • Market Cap
  • UNCY 74.2M
  • MDIA 72.4M
  • IPO Year
  • UNCY 2021
  • MDIA N/A
  • Fundamental
  • Price
  • UNCY $3.94
  • MDIA $1.42
  • Analyst Decision
  • UNCY Strong Buy
  • MDIA
  • Analyst Count
  • UNCY 5
  • MDIA 0
  • Target Price
  • UNCY $55.20
  • MDIA N/A
  • AVG Volume (30 Days)
  • UNCY 520.0K
  • MDIA 26.8K
  • Earning Date
  • UNCY 11-12-2025
  • MDIA 11-13-2025
  • Dividend Yield
  • UNCY N/A
  • MDIA N/A
  • EPS Growth
  • UNCY N/A
  • MDIA N/A
  • EPS
  • UNCY N/A
  • MDIA 0.40
  • Revenue
  • UNCY N/A
  • MDIA $121,938,000.00
  • Revenue This Year
  • UNCY N/A
  • MDIA N/A
  • Revenue Next Year
  • UNCY $4,481.14
  • MDIA N/A
  • P/E Ratio
  • UNCY N/A
  • MDIA $3.51
  • Revenue Growth
  • UNCY N/A
  • MDIA 165.75
  • 52 Week Low
  • UNCY $3.40
  • MDIA $0.79
  • 52 Week High
  • UNCY $11.00
  • MDIA $2.31
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 37.53
  • MDIA 58.23
  • Support Level
  • UNCY $4.23
  • MDIA $1.37
  • Resistance Level
  • UNCY $4.43
  • MDIA $1.50
  • Average True Range (ATR)
  • UNCY 0.19
  • MDIA 0.08
  • MACD
  • UNCY -0.01
  • MDIA 0.01
  • Stochastic Oscillator
  • UNCY 22.22
  • MDIA 66.50

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About MDIA Mediaco Holding Inc.

MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.

Share on Social Networks: